142 related articles for article (PubMed ID: 2022974)
1. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
Rozental JM; Levine RL; Nickles RJ
J Neurooncol; 1991 Feb; 10(1):75-83. PubMed ID: 2022974
[TBL] [Abstract][Full Text] [Related]
2. Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme.
Rozental JM; Cohen JD; Mehta MP; Levine RL; Hanson JM; Nickles RJ
J Neurooncol; 1993 Jan; 15(1):57-66. PubMed ID: 8384254
[TBL] [Abstract][Full Text] [Related]
3. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Rozental JM; Levine RL; Nickles RJ; Dobkin JA
Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathology and survival by FDG PET in gliomas.
Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
[TBL] [Abstract][Full Text] [Related]
5. Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy.
Rozental JM; Levine RL; Mehta MP; Kinsella TJ; Levin AB; Algan O; Mendoza M; Hanson JM; Schrader DA; Nickles RJ
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1053-60. PubMed ID: 2022505
[TBL] [Abstract][Full Text] [Related]
6. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
Kim CK; Alavi JB; Alavi A; Reivich M
J Neurooncol; 1991 Feb; 10(1):85-91. PubMed ID: 2022975
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
8. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
9. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
10. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Shishido F; Uemura K
Cancer; 1994 May; 73(9):2386-94. PubMed ID: 8168042
[TBL] [Abstract][Full Text] [Related]
11. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
12. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of regional blood flow, blood volume, oxygen extraction fraction, and metabolic rates of oxygen and glucose as measured by positron emission tomography in patients with gliomas].
Mineura K; Suda Y; Sasajima T; Yasuda T; Kowada M; Ogawa T; Shishido F; Uemura K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2556-62. PubMed ID: 2614191
[TBL] [Abstract][Full Text] [Related]
14. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography in patients with glioma. A predictor of prognosis.
Alavi JB; Alavi A; Chawluk J; Kushner M; Powe J; Hickey W; Reivich M
Cancer; 1988 Sep; 62(6):1074-8. PubMed ID: 3261622
[TBL] [Abstract][Full Text] [Related]
16. Glucose consumption in recurrent gliomas.
Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
[TBL] [Abstract][Full Text] [Related]
17. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma.
Hölzer T; Herholz K; Jeske J; Heiss WD
J Comput Assist Tomogr; 1993; 17(5):681-7. PubMed ID: 8370819
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
Herholz K; Ziffling P; Staffen W; Pawlik G; Wagner R; Wienhard K; Heiss WD
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1139-50. PubMed ID: 3262062
[TBL] [Abstract][Full Text] [Related]
20. Effects of hyperglycemia on FDG uptake in human brain and glioma.
Ishizu K; Nishizawa S; Yonekura Y; Sadato N; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Miyatake S; Ishikawa M
J Nucl Med; 1994 Jul; 35(7):1104-9. PubMed ID: 8014665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]